芩橘清热利咽方治疗上呼吸道感染的临床效果分析

Treating upper respiratory tract infection with the Qinju Qingre Liyan prescription

目的:评价芩橘清热利咽方治疗上呼吸道感染的临床应用效果。方法:将2017年1-12月我院收治的72例上呼吸道感染患者随机平分为两组。(1)西医治疗组:选用奥司他韦、抗生素、盐酸氨溴索、右美沙芬、布洛芬、对乙酰氨基酚、布地奈德等进行对症治疗;(2)中医治疗组:选用芩橘清热利咽方进行治疗。比较各组别的临床疗效、不良反应发生率以及干预前后患者伴随症状改善的差异。结果:(1)治疗上呼吸道感染的临床疗效:中医治疗组的总有效率为97.22%,显著高于西医治疗组的83.33%,差异有统计学意义(P <0.05);(2)不良反应发生率:中医治疗组为8.33%,明显低于西医治疗组的27.78%,差异有统计学意义(P <0.05);(3)症状改善评分:干预前两组患者伴随症状评分相似,差异无统计学意义(P> 0.05);干预后中医治疗组患者的伴随症状改善较之西医治疗组更为显著,差异有统计学意义(P <0.05)。结论:芩橘清热利咽方治疗上呼吸道感染的临床效果确切,明显改善上呼吸道感染症状,不良反应少,用药安全性高,可显著提高患者的生活质量。

Objective:To investigate clinical efficacy of the Qinju Qingre Liyan prescription(芩橘清热利咽方)on upper respiratory tract infection.Methods:72 cases were divided into two groups.The western medicine treatment group was given symptomatic treatment,including oseltamivir,antibiotics,ambroxol hydrochloride,dextromethorphan,ibuprofen,acetaminophen,budesonide,etc..The TCM treatment group was given the Qinju Qingre Liyan prescription.Results:The total efficiency in the TCM treatment group was 97.22%,significantly higher than 83.33%in the western medicine treatment group(P<0.05).The incidence of adverse reactions in the TCM treatment group was 8.33%,significantly lower than 27.78%in the western medicine treatment group(P<0.05).After treatment,the associated symptoms were improved more significantly in the TCM treatment group(P<0.05).Conclusion:The Qinju Qingre Liyan prescription on upper respiratory tract infection shows a good effect,can improve the quality of life,with less adverse reactions and safe.